A Phase I/II Open-Label Safety and Dose-Finding Study of Adeno- Associated Virus (AAV) rh10-Mediated Gene Transfer of Human Factor IX in Adults With Moderate/Severe to Severe Hemophilia B
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Dimension Therapeutics, Inc.
Start Date
October 10, 2016
End Date
February 28, 2018
Administered By
Medicine, Hematology
Awarded By
Dimension Therapeutics, Inc.
Start Date
October 10, 2016
End Date
February 28, 2018